Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

This study will assess the safety and effectiveness of fimaporfin-induced photochemical internalisation (PCI) of gemcitabine complemented by systemic gemcitabine/cisplatin chemotherapy compared to gemcitabine/cisplatin alone, in patients with inoperable cholangiocarcinoma (CCA). Participants will be randomly assigned to one of the treatment groups and will receive study treatment for 6 months, followed …

cholestasis
drainage
metastasis
adenocarcinoma
cisplatin/gemcitabine
  • 5 views
  • 30 Jan, 2021
  • 61 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

) Intrahepatic cholangiocarcinoma (closed to accrual 03/20/2018) Extrahepatic cholangiocarcinoma and bile duct tumors (closed to accrual 03/20/2018) Sarcomatoid carcinoma of

squamous cell carcinoma of head and neck
lipase
metastatic disease
carcinoma lung
other cancer
  • 5957 views
  • 25 Jul, 2021
  • 814 locations
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma

-positive extrahepatic cholangiocarcinoma.

metastasis
adjuvant chemotherapy
serum total bilirubin
capecitabine
malignant disease
  • 15 views
  • 24 Jan, 2021
  • 1 location
Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

The purpose of this study is to evaluate the feasibility, efficacy and safety of FORFIRINOX in advanced or recurrent extrahepatic cholangiocarcinoma and gallbladder carcinoma.

  • 0 views
  • 22 Jan, 2021
  • 1 location
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

extrahepatic cholangiocarcinoma and gallbladder carcinoma.

mates
extrahepatic cholangiocarcinoma
tyrosine
cholangiocarcinoma
carcinoma
  • 14 views
  • 22 Jan, 2021
  • 1 location
A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer

Target population: patients with advanced biliary tract cancer (including gallbladder carcinoma, intrahepatic and extrahepatic cholangiocarcinoma) . Primary objective

  • 0 views
  • 22 Jan, 2021
  • 1 location
Two-in-one Covered and Uncovered Metal Stent

Endoscopic placement of a self-expandable metal stent (SEMS) is the principle method for palliation of inoperable malignant distal biliary obstruction. However, none of bare, covered, and anti-reflux metal stent alone constantly demonstrated superiority over the others in the stent patency. To compensate for the limitations of each stent, a double …

metastasis
obstruction
reflux
biliary obstruction
  • 0 views
  • 25 Jul, 2021
  • 1 location
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC)

psychiatric disorder
antibiotics
biliary tract cancer
metastasis
gallbladder carcinoma
  • 2 views
  • 26 Jan, 2021
  • 1 location
Ramucirumab in Treating Patients With Advanced or Metastatic Previously Treated Biliary Cancers That Cannot Be Removed by Surgery

This phase II trial studies how well ramucirumab works in treating patients with previously treated biliary cancers that have spread to other places in the body and usually cannot be cured or controlled with treatment (advanced) or have spread to other places in the body (metastatic) and cannot be removed …

gallbladder cancer
metastasis
adenocarcinoma
tumor cells
neutrophil count
  • 0 views
  • 25 Jan, 2021
  • 1 location
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)

PLATON (Platform for Analyzing Targetable Mutations) is a prospective, multicentre, observational cohort study with biobanking. In a first approach PLATON's pilot-study assesses genomic profiling in gastrointestinal cancer therapy and the frequencies of targetable mutations including Tumor Mutational Burden (TMB) and Microsatellite Instability Status (MSI), performing Next-generation deep sequencing (NGS) using …

  • 0 views
  • 28 Jan, 2021
  • 3 locations